| Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment JJP Kastelein, WA Van Der Steeg, I Holme, M Gaffney, NB Cater, P Barter, ... Circulation 117 (23), 3002-3009, 2008 | 981* | 2008 |
| Multicenter, placebo-controlled trial of lorcaserin for weight management SR Smith, NJ Weissman, CM Anderson, M Sanchez, E Chuang, S Stubbe, ... New England Journal of Medicine 363 (3), 245-256, 2010 | 963 | 2010 |
| Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management SR Smith, NJ Weissman, CM Anderson, M Sanchez, E Chuang, S Stubbe, ... N Engl J Med 363 (3), 245-256, 2010 | 262 | 2010 |
| Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management SR Smith, NJ Weissman, CM Anderson, M Sanchez, E Chuang, S Stubbe, ... N Engl J Med 363 (3), 245-256, 2010 | 262 | 2010 |
| High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. BA Haber, S Chin, E Chuang, W Buikhuisen, A Naji, R Taub The Journal of clinical investigation 95 (2), 832-841, 1995 | 169 | 1995 |
| Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients S Plevy, MS Silverberg, S Lockton, T Stockfisch, L Croner, J Stachelski, ... Inflammatory bowel diseases 19 (6), 1139-1148, 2013 | 168 | 2013 |
| A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active … B Yacyshyn, WY Chey, MK Wedel, ZY Rosie, D Paul, E Chuang Clinical Gastroenterology and Hepatology 5 (2), 215-220, 2007 | 136 | 2007 |
| A phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis SJH Van Deventer, MK Wedel, BF Baker, S Xia, E Chuang, PB Miner Jr Alimentary pharmacology & therapeutics 23 (10), 1415-1425, 2006 | 133 | 2006 |
| Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay SL Wang, S Hauenstein, L Ohrmund, R Shringarpure, J Salbato, R Reddy, ... Journal of pharmaceutical and biomedical analysis 78, 39-44, 2013 | 99 | 2013 |
| Challenges in IBD research: environmental triggers SM Ho, JD Lewis, EA Mayer, CN Bernstein, SE Plevy, E Chuang, ... Inflammatory bowel diseases 25 (Supplement_2), S13-S23, 2019 | 98 | 2019 |
| Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior GR Lichtenstein, SR Targan, MC Dubinsky, JI Rotter, DM Barken, ... Inflammatory bowel diseases 17 (12), 2488-2496, 2011 | 91 | 2011 |
| A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads MP Jones, WD Chey, S Singh, H Gong, R Shringarpure, N Hoe, ... Alimentary pharmacology & therapeutics 39 (4), 426-437, 2014 | 87 | 2014 |
| Molecular pathophysiology of epithelial barrier dysfunction in inflammatory bowel diseases JY Lee, VC Wasinger, YY Yau, E Chuang, V Yajnik, RWL Leong Proteomes 6 (2), 17, 2018 | 80 | 2018 |
| Long-term growth and development in children after home parenteral nutrition BL Leonberg, E Chuang, P Eicher, AM Tershakovec, L Leonard, ... The Journal of pediatrics 132 (3), 461-466, 1998 | 75 | 1998 |
| Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea‐predominant IBS F Cremonini, JP Nicandro, V Atkinson, R Shringarpure, E Chuang, ... Alimentary pharmacology & therapeutics 36 (5), 437-448, 2012 | 71 | 2012 |
| Intravenous sedation in pediatric upper gastrointestinal endoscopy E Chuang, WJ Wenner Jr, DA Piccoli, SM Altschuler, CA Liacouras Gastrointestinal endoscopy 42 (2), 156-160, 1995 | 71 | 1995 |
| Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis PB Miner Jr, RS Geary, J Matson, E Chuang, S Xia, BF Baker, MK Wedel Alimentary pharmacology & therapeutics 23 (10), 1427-1434, 2006 | 69 | 2006 |
| Primary sclerosing cholangitis in children: a histologic follow-up study LA Batres, P Russo, M Mathews, DA Piccoli, E Chuang, E Ruchelli Pediatric and Developmental Pathology 8 (5), 568-576, 2005 | 62 | 2005 |
| A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program K Tong, JP Nicandro, R Shringarpure, E Chuang, L Chang Therapeutic advances in gastroenterology 6 (5), 344-357, 2013 | 61 | 2013 |
| APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia R Rosenberg, DJ Seiden, SG Hull, M Erman, H Schwartz, C Anderson, ... Sleep 31 (12), 1663-1671, 2008 | 56 | 2008 |
